Merck loses bid to revive over Rs 18 crore patent verdict against Gilead Farhat Nasim31 Oct 2019 9:57 AM GMTIn 2016, a jury returned a verdict that Gilead Science's hepatitis C drugs Sovaldi and Harvoni infringed the patent, which Merck acquired when it...
Laurus Labs to acquire subsidiary of ASPEN Pharmacare Farhat Nasim24 Sep 2019 4:00 AM GMT"The completion of conditions precedent, by way of cash consideration of ZAR 75,000, the Pharmaceutical company said in a statement here. The...
Gilead licenses respiratory, herpes antiviral research programs from Novartis Medical Dialogues Bureau23 July 2019 3:45 AM GMTUnder the agreement, Gilead will acquire exclusive global rights to develop and commercialize novel small molecules against three undisclosed targets....
Gilead to raise stake in Belgian Biotech Galapagos in USD 5.1 billion deal: Report Medical Dialogues Bureau15 July 2019 4:00 AM GMTThe deal is the largest Gilead has executed since new Chief Executive Officer Dan O'Day took the reins in March as he attempts to bolster the San...
CDSCO releases Risk classification of newly notified Medical Devices, IVDs; Details Meghna A Singhania18 May 2019 8:38 AM GMTNew Delhi: Through a recent notification, country's central medical device regulator, the Central Drugs Standards Control Organization (CDSCO) has...
AbbVie wins USFDA nod for Mavyret to treat HCV genotypes in pediatric patients Farhat Nasim3 May 2019 3:40 AM GMTNew Delhi: AbbVie Inc. recently won the U.S. Food and Drug Administration (USFDA) approval for Mavyret (glecaprevir and pibrentasvir) tablets to treat...
US court upholds dismissal of 200 million dollars Merck verdict against Gilead Ruby Khatun Khatun27 April 2018 4:00 AM GMTA U.S. appeals court affirmed a ruling that pharmaceutical company Merck & Co dishonestly obtained patent rights and was not entitled to collect a...
CDSCO releases Risk classification of Medical Devices and IVDs savita thakur thakur8 Nov 2017 9:54 AM GMTThrough a recent notification, Drugs Controller General (India), Directorate General of Health Services, India's central medical device regulator, the...
Merck to stop development of hepatitis C treatments Ruby Khatun Khatun4 Oct 2017 4:50 AM GMTU.S. drugmaker Merck & Co said on Friday it would discontinue developing an experimental drug combination for chronic hepatitis C, as competition...
Johnson and Johnson arm Janssen to discontinue Hepatitis C development program Ruby Khatun Khatun14 Sep 2017 4:32 AM GMTCORK, Ireland: Janssen Sciences Ireland UC (Janssen), announced a strategic decision to discontinue further development of the investigational...
Co-Diagnostics to sign purchase agreement with MEDCIS Pathlabs Ruby Khatun Khatun9 Sep 2017 4:04 AM GMTSANDY, Utah: Co-Diagnostics, Inc. ("Co-Diagnostics" or the "Company"), a molecular diagnostics company with a unique, proprietary platform for the...
FDA approves Mavyret for Hepatitis C Ruby Khatun Khatun10 Aug 2017 4:15 AM GMTThe U.S. Food and Drug Administration (FDA) approved Mavyret (glecaprevir and pibrentasvir) to treat adults with chronic hepatitis C virus (HCV)...
